4-173021569-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001034845.3(GALNTL6):c.1582G>A(p.Val528Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000706 in 1,614,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001034845.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALNTL6 | NM_001034845.3 | c.1582G>A | p.Val528Ile | missense_variant | 12/13 | ENST00000506823.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALNTL6 | ENST00000506823.6 | c.1582G>A | p.Val528Ile | missense_variant | 12/13 | 1 | NM_001034845.3 | P1 | |
GALNTL6 | ENST00000508122.5 | c.1531G>A | p.Val511Ile | missense_variant | 11/12 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152166Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251378Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135862
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461834Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 727216
GnomAD4 genome AF: 0.000112 AC: 17AN: 152284Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 7AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.1582G>A (p.V528I) alteration is located in exon 12 (coding exon 11) of the GALNTL6 gene. This alteration results from a G to A substitution at nucleotide position 1582, causing the valine (V) at amino acid position 528 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at